Thalidomide-O-PEG4-Boc ddCTP In cells treated with Dibutyryl-cGMP

In cells treated with Dibutyryl-cGMP (100 μM

5-b]pyridine was synthezed by reduction of 2-amino-3-nitropyridine derivatives to the corresponding diaminopyridine which was then condensed with an appropriate carboxylic acid in polyphosphoric acid

Arjunolic acid is a new multifunctional therapeutic promise of alternative medicine

InChi: InChI=1S/C38H35N7O3Si/c1-49(2)33-20-27(44-15-3-16-44)10-13-30(33)35(31-14-11-28(21-34(31)49)45-17-4-18-45)32-19-26(9-12-29(32)38(47)48)37(46)39-22-24-5-7-25(8-6-24)36-42-40-23-41-43-36/h5-14

CC1=NC=CC=C1OC1=CC=C(C=N1)NC(=O)N1CCC2=CC(C)=C(C=C12)C(F)(F)F

Thalidomide-O-PEG4-Boc ddCTP In cells treated with Dibutyryl-cGMPThalidomide O PEG4 Boc is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 2411681 87 1 Molecular Weight: 578. 61 Formula: C28H38N2O11 Chemical Name: tert butyl 1 {[2 (2,6 dioxopiperidin 3 yl) 1,3 dioxo 2,3 dihydro 1H isoindol 4 yl]oxy} 3,6,9,12 tetraoxapentadecan 15 oate Smiles: CC(C)(C)OC(=O)CCOCCOCCOCCOCCOC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O InChiKey: FBMJFOLUGBQIKU UHFFFAOYSA N InChi: